Take compliance off the back burner: 3 risks of ignoring interoperability in 2026
Read time: 10 min
Summary
USCDI has advanced rapidly since its establishment in 2020. USCDI Version 3 – mandatory starting Jan. 1, 2026 – more than doubles the scope of Version 1. Yet, many health systems and health IT developers still treat it as optional, risking severe penalties, including hefty fines, reimbursement delays, and legal action.
This insight brief details what’s at stake and how expert-maintained clinical terminology can prevent compliance issues before they become costly.
Key learnings
The most significant financial and legal costs of interoperability non-compliance
How up-to-date clinical terminology supports compliance and protects revenue integrity
Why proactive adoption of interoperability standards is essential for future-readiness
Featured speaker(s)
April Curtis
Marketing Director
IMO
Thomas Magnum
Marketing Manager
IMO
B.A. Baracus
Data Analyst
IMO
B.A. Baracus
Data Analyst
IMO
Who It's For
Download the insight brief
Optional Section Title
This is a full-width section inside a light grey background, styled using only inline styles and Bootstrap classes.
